[ad_1]
In the last 24 hours, Portugal registered 4,044 new cases of infection and 74 more deaths associated with the Covid-19 disease, according to the bulletin of the General Directorate of Health (DGS) this Monday.
Since the beginning of the pandemic in Portugal, 3,971 people have died of the 264,802 confirmed cases of infection.
See below the live press conference with the general director of Health, Graça Freitas:
There are 7 more patients admitted to the Intensive Care Units, adding 498, a new maximum since the start of the pandemic. In terms of hospital admissions, there are more than 90 people hospitalized, now totaling 3,241.
DGS reveals that 62 more cases of infection are active compared to Thursday, for a total of 84,004. An additional 3,908 patients were recovered, 176,827 since the start of the pandemic.
Health authorities now have 82,025 people under surveillance.
With regard to 4,044 new cases, 2,258 were registered in the north, 1,052 in Lisbon and Vale do Tejo, 490 in the Center region, 68 in Alentejo, 126 in the Algarve, 31 in the Azores and 19 in Madeira.
Of the 74 deaths that are lamented in the last 24 hours, 35 occurred in the North, 26 in Lisbon and the Tagus Valley, 10 in the Center, two in Alentejo and one in the Algarve.
DATA BY GENDER AND AGE RANGE
Confirmed cases are distributed in all age groups, with the highest number of infections between 20 and 59 years.
The new coronavirus has already infected at least 116,915 men and 143,055 women in Portugal, according to reported cases.
Today’s bulletin indicates that there are 4,832 confirmed cases of unknown sex that are under investigation, as this data is not automatically released.
Of the total deaths, 2,056 were men and 1,915 women.
The highest number of deaths is still concentrated in people over 80 years of age.
See here the complete document with the new measures for the state of emergency.
At midnight, we have a Portugal at four speeds, due to the seriousness of the risk of contagion by Covid-19.
The main novelty is the maintenance of the measures applied on weekends for the municipalities with the highest risk and also the prohibition of driving between municipalities on the two long weekends in December.
Prime Minister António Costa admits that the country may have to live in a state of emergency for at least another month to try to control the pandemic.
Learn more about the new measures through the official website covid19estamoson.gov.pt
AstraZeneca announced on Monday that the vaccine for the new coronavirus, developed in partnership with the University of Oxford, showed an average effectiveness of 70% in protecting against the virus in two segments of the study.
Given Ruvic
The vaccine for the new coronavirus developed by the University of Oxford prevents 70% of people from developing covid-19based on interim results from large-scale clinical trials conducted in the UK and Brazil, says AstraZeneca.
How does he BBC these results can be a triumph and at the same time a disappointment after the results announced by the pharmaceutical companies Pfizer and Moderna, where the demonstrated efficacy exceeded 90%.
However, the Oxford vaccine is much cheaper, easier to store and to reach all corners of the world than the other two, which may mean that it will play an important role in the fight against the pandemic, if it is approved by the regulators. says the BBC. This vaccine can be stored, transported and handled under normal refrigeration conditions (2-8 degrees Celsius) for at least six months.
The Oxford researchers went through the normal process of developing a vaccine, which would take a decade in just 10 months.
Second note released, no hospitalizations or serious cases of the disease have been reported among the trial participants who received the vaccine and there were 131 cases of covid-19 recorded in the interim analysis.
“Today’s announcement [segunda-feira] brings us closer to the time when we can use vaccines to end the devastation caused [pelo vírus]”Said the head of vaccine development, Sarah Gilbert.
The pharmaceutical company adds that effectiveness can even reach 90% “under a dosing regimen”.
One dosing regimen showed 90% vaccine efficacy when initially administered in half the dose, followed by a full dose at least one month apart. Another dosing regimen showed 62% efficacy when administered in two full doses at least one month apart.
A The combined analysis of both dosage regimens results in an average efficacy of 70%.explains the company, adding that “more data will continue to be accumulated and more analyzes will be developed, refining the reading of the effectiveness to establish the duration of the protection” conferred.
